# Prostate cancer blood test detects twice as many cases

> **Newsylist Open Intelligence Dossier** · First detected: 2026-06-24 11:24 UTC · Category: Health · Sources: 5 · Current Velocity: 2.8

## Executive Summary
A new multicomponent blood test is outperforming traditional PSA screenings in detecting clinically significant prostate cancer.

## Intelligence Brief
A new blood test, identified in coverage as Stockholm3, is demonstrating a higher detection rate for high-risk and clinically significant prostate cancer cases. According to The Telegraph, the test detects twice as many cases as previous methods.


Reporting from MedPage Today, 2 Minute Medicine, and Medical Xpress emphasizes that this multicomponent test tops the traditional PSA (Prostate-Specific Antigen) test in performance. AuntMinnie notes that blood-based testing could further improve screening when used in conjunction with MRI.


Coverage focuses on the test's ability to identify high-risk cases more effectively than the PSA. Future developments involve the integration of these blood tests with imaging technologies like MRI to enhance screening outcomes.

## Verified Facts & Key Claims
### What is the name of the new blood test?
The test is referred to as Stockholm3 in coverage from 2 Minute Medicine.

### How does it compare to the PSA test?
The test is reported to outperform the PSA for detecting significant prostate cancer, with The Telegraph stating it detects twice as many cases.

### Can this test be used with other diagnostic tools?
According to AuntMinnie, blood-based testing could improve screening when used with MRI.

## Key People, Organizations & Locations
MRI, Prostate, Blood-based, PSA, Multicomponent Test Tops PSA for Clinically Significant Prostate Cancers, Stockholm3

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| MedPage Today | Multicomponent Test Tops PSA for Clinically Significant Prostate Cancers | 2026-06-22 21:00 | [Source Link](https://news.google.com/rss/articles/CBMieEFVX3lxTE5FUTNmZjA4NnlPY2FOTUUyWnFTcS1HUGxfY214TVd1VXVkNm5ab3RBWmhNLUIwaDZoeF9lME81OGtNaFNPNWJ0VHhJdkhIUDR5MGdHMWluVmp2dXhUNDJEMHdpVnpTMTdZV010aVlWeHlSdURoWW12Tw?oc=5) |
| AuntMinnie | Blood-based testing could improve prostate cancer screening with MRI | 2026-06-22 21:00 | [Source Link](https://news.google.com/rss/articles/CBMiyAFBVV95cUxPTjUyMWhPeEpuQjB1ZF9nRFBnSFE5bDhSbGhIbUFoSGpXX1V0ak5sU3puc0lCa21kLTZMSXBDQTFLQXFjNU1oa3hqbXU5WkNiUDlod3d4clI3SHliOUlyTk9VY1RRdUl4Z3JfZGdYLVBCRUZKTGR5VEJ0UFVWQUdEU2JEb3FJSTdNWk1fRUUxQmlYSVlVMXBmRktsUlp5SDkwcnZHeXFuWVg5MFczZTJpWFlfYVNYU085X0VTVW5lQmQzWkVIZVpEWQ?oc=5) |
| 2 Minute Medicine | Stockholm3 outperforms PSA for detecting significant prostate cancer | 2026-06-22 21:00 | [Source Link](https://news.google.com/rss/articles/CBMiowFBVV95cUxOQ0NwV3pGSm9sVktkdDFHR2NUbmRPQjZzaVRyRGpqYXk1YWtlVktmRW1XOXNpZHQ5bkZ0V3pJQ0dUa3p5YzFDVHpCUlRwbS16NDF2dk8wUC1LalZCWm5uNFdxOUJRcDFyUGY1a0JBeWo5MTJyTUtXc28tMnloZW1PdHNWcXh6eDh4YWNMZ2ZyT3lhZmxZV0N2YW9MYm9ENVZ0NXJF?oc=5) |
| Medical Xpress | New blood test detects more high-risk prostate cancer cases | 2026-06-22 21:00 | [Source Link](https://news.google.com/rss/articles/CBMiggFBVV95cUxQam1va05WdUZJM2hUZHFwRFZpTXFkcXY4d21BcG1NWjJHeEthbGtHVUJzWk4yQnd6NjdtY09maVdFODMyTWFfTWxoenc4ckl3Z0JuZFl6cFJpUVFObjRrVVZJa3NKNnFjaElRM1BIS1kxM0ZVZkIxVjNEaUlPVXZkcmFB?oc=5) |
| The Telegraph | Prostate cancer blood test detects twice as many cases | 2026-06-22 21:00 | [Source Link](https://news.google.com/rss/articles/CBMilwFBVV95cUxPemJscUdSVWp3aTQzd3pSXzhtaGRtV2JBbXAtNERwQ1V2TE55Si14MXdCMW1TU3doSjdfa2kwNllvQjhlN1dmczkyZ0lqdGt2T051aF9LSFBSd3FCVU9laG0wUE1hTENWWDdidVNxUnhSSkl3ZmtsNEpMeXlPVVVFcE00ejRVOGt5cm8xd045Yl9fTXNfZzRZ?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-06-24/prostate-cancer-blood-test-detects-twice-as-many-cases*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*